Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > News
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(24)
•••
Comment by Fejjy2016on Dec 19, 2016 9:19am
141 Views
Post# 25618438

RE:News

RE:News
These guys sound like newbies to the MJ world the way this news release is worded. Big pharma guys with money behind them trying to figure out how to get s big hold of this market.

there are liscended producers miles ahead of these guys already. Looks like they are in tight with government, which like all things does count for something, but can they win the hearts and minds of buyers?

Will keep watching but sounds like a lot of promises so far. At 2.80, I'll wait it out.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities